These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11491585)

  • 21. Glutamate receptor antagonism in inferior colliculus attenuates elevated startle response of high anxiety diazepam-withdrawn rats.
    Cabral A; De Ross J; Castilho VM; Brandão ML; Nobre MJ
    Neuroscience; 2009 Jul; 161(3):707-17. PubMed ID: 19348870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T; Nozaki S; Inagaki A; Furukawa TA
    Hum Psychopharmacol; 2003 Aug; 18(6):483-7. PubMed ID: 12923829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults.
    Salazar DE; Frackiewicz EJ; Dockens R; Kollia G; Fulmor IE; Tigel PD; Uderman HD; Shiovitz TM; Sramek JJ; Cutler NR
    J Clin Pharmacol; 2001 Dec; 41(12):1351-8. PubMed ID: 11762563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 26. The risk of pharmacological dependence with buspirone.
    Tyrer P; Murphy S; Owen RT
    Br J Clin Pract Suppl; 1985 May; 38():91-4. PubMed ID: 2862909
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diazepam conversion in older adults.
    Vogel EA; Klockars SJ; Billups SJ; Dugan JP
    J Am Geriatr Soc; 2010 Jun; 58(6):1204-5. PubMed ID: 20722860
    [No Abstract]   [Full Text] [Related]  

  • 29. Diazepam use during pregnancy: a review of the literature.
    Iqbal MM; Sobhan T; Aftab SR; Mahmud SZ
    Del Med J; 2002 Mar; 74(3):127-35. PubMed ID: 11963349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R; Sartori VA; Seabra ML; Leite JR
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].
    Molodavkin GM; Cadikov MK; Voronina TA; Sadikova ZU; Meletova OK; Pchelkina MI; Larentsova LI; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2004; 67(6):16-9. PubMed ID: 15707007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buspirone Abuse by Insufflation: A Case Report.
    Swigart A
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):89-90. PubMed ID: 33208707
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
    Nishikawa H; Inoue T; Masui T; Izumi T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):926-31. PubMed ID: 17376576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats.
    Farooq R; Haleem DJ; Haleem MA
    Pak J Pharm Sci; 2007 Oct; 20(4):295-9. PubMed ID: 17604252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seizures associated with buspirone overdose: case report and literature review.
    Catalano G; Catalano MC; Hanley PF
    Clin Neuropharmacol; 1998; 21(6):347-50. PubMed ID: 9844791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I have heard that buspirone regularly affects various blood tests. Is this so?
    Shader RI
    J Clin Psychopharmacol; 1996 Apr; 16(2):194. PubMed ID: 8690840
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in glucose, cholesterol and serum lipid fraction levels in experimental diabetes.
    Maciejewski R; Ruciński P; Burski K; Figura T
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():363-8. PubMed ID: 11977341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F
    J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.
    Majercsik E; Haller J; Leveleki C; Baranyi J; Halász J; Rodgers RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Dec; 27(8):1187-99. PubMed ID: 14659474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
    Leveleki C; Sziray N; Levay G; Barsvári B; Soproni K; Mikics E; Haller J
    Brain Res Bull; 2006 Mar; 69(2):153-60. PubMed ID: 16533664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.